Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacogenetics and Pharmacogenomics: Overview01:29

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
Pharmacogenetics of Drug Metabolism: Overview01:27

Pharmacogenetics of Drug Metabolism: Overview

Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Leadership, Informatics Expertise, and Resources: Determinants of Institutional Data Sharing in the National Clinical Cohort Collaborative (N3C).

AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science·2026
Same author

A Primary Open-Angle Glaucoma Locus Near Transcription Factor <i>PRRX1</i> Identified in the Million Veteran Program.

Ophthalmology science·2026
Same author

Shared Genetic Architecture Between Kidney Function and Alzheimer Disease Across Ancestries.

medRxiv : the preprint server for health sciences·2026
Same author

Whole-genome sequence genome-wide association study in <i>All of Us</i> identifies a novel glaucoma risk locus in African ancestry individuals.

medRxiv : the preprint server for health sciences·2026
Same author

Dissecting Alzheimer's disease heritability across populations.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Evidence for reduced somatic T-cell receptor sequence diversity profiles among Midwestern Amish in an aging cohort study.

medRxiv : the preprint server for health sciences·2026
Same journal

Brexpiprazole for anxiety symptoms in people living with schizophrenia: a plain language summary.

Expert review of clinical pharmacology·2026
Same journal

The systems medicine view of semaglutide: from clinical trials to molecular mechanisms.

Expert review of clinical pharmacology·2026
Same journal

Beyond snapshot dosing: a dynamic living digital twin framework for model-informed precision dosing in critical illness.

Expert review of clinical pharmacology·2026
Same journal

Understanding the relationship between aripiprazole levels in the blood and recurrence of mood episodes in people diagnosed with bipolar I disorder treated with a once-monthly injection of aripiprazole monohydrate: a plain language summary.

Expert review of clinical pharmacology·2026
Same journal

Tirzepatide in type 1 diabetes: beyond mere weight loss.

Expert review of clinical pharmacology·2026
Same journal

Prophylaxis for inherited factor X deficiency: a systematic review.

Expert review of clinical pharmacology·2026
See all related articles

Related Experiment Video

Updated: Jun 15, 2026

Large-Scale Multi-Omics Genome-Wide Association Studies (Mo-GWAS): Guidelines for Sample Preparation and Normalization
08:27

Large-Scale Multi-Omics Genome-Wide Association Studies (Mo-GWAS): Guidelines for Sample Preparation and Normalization

Published on: July 27, 2021

Methods for optimizing statistical analyses in pharmacogenomics research.

Stephen D Turner1, Dana C Crawford, Marylyn D Ritchie

  • 1Center for Human Genetics Research, Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville TN, 37232, USA, Tel.: +1 615 343 6549, , stephen@chgr.mc.vanderbilt.edu.

Expert Review of Clinical Pharmacology
|March 12, 2010
PubMed
Summary
This summary is machine-generated.

Pharmacogenomics research links genetic variation to drug response. This study focuses on optimizing statistical methods for analyzing continuous drug response traits in pharmacogenomic studies.

More Related Videos

A Protocol for Using Gene Set Enrichment Analysis to Identify the Appropriate Animal Model for Translational Research
09:35

A Protocol for Using Gene Set Enrichment Analysis to Identify the Appropriate Animal Model for Translational Research

Published on: August 16, 2017

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

Related Experiment Videos

Last Updated: Jun 15, 2026

Large-Scale Multi-Omics Genome-Wide Association Studies (Mo-GWAS): Guidelines for Sample Preparation and Normalization
08:27

Large-Scale Multi-Omics Genome-Wide Association Studies (Mo-GWAS): Guidelines for Sample Preparation and Normalization

Published on: July 27, 2021

A Protocol for Using Gene Set Enrichment Analysis to Identify the Appropriate Animal Model for Translational Research
09:35

A Protocol for Using Gene Set Enrichment Analysis to Identify the Appropriate Animal Model for Translational Research

Published on: August 16, 2017

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

Area of Science:

  • Human Genetics
  • Pharmacogenomics
  • Statistical Genetics

Background:

  • Pharmacogenomics investigates how genetic variations influence individual drug responses.
  • Understanding genetic contributions to drug efficacy and toxicity is crucial for personalized medicine.
  • Significant research is dedicated to identifying genetic variants associated with drug-response phenotypes.

Purpose of the Study:

  • To discuss principles of study design in pharmacogenomics.
  • To optimize statistical methods for analyzing continuous pharmacogenomic traits.
  • To review traditional and novel analytical approaches for quantitative pharmacogenomic data.

Main Methods:

  • Discussion of study design principles for pharmacogenomic research.
  • Review of traditional hypothesis testing procedures.
  • Exploration of novel statistical approaches for quantitative traits.

Main Results:

  • Identified key considerations for study population, phenotype, and statistical methodology.
  • Presented traditional and novel statistical methods for analyzing continuous pharmacogenomic data.
  • Provided examples of studies utilizing discussed methodologies and software resources.

Conclusions:

  • Careful consideration of study design and statistical methods is essential for maximizing the benefits of pharmacogenomic data.
  • Optimized statistical approaches can better account for variance in quantitative pharmacogenomic traits.
  • The study offers guidance and resources for conducting robust pharmacogenomic analyses.